Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma.
D000941:Antigens; D002051:Burkitt Lymphoma / Q000276:immunology* / Q000473:pathology; D002460:Cell Line; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D006564:Herpesviridae / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D037102:Lectins / Q000494:pharmacology; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008722:Methods; D009303:Nasopharyngeal Neoplasms / Q000276:immunology / Q000473:pathology; D013936:Thymidine; D014316:Tritium
D000941:Antigens; D037102:Lectins; D014316:Tritium; D013936:Thymidine